Fresenius Medical Care AG

XTRA:FME Stok Raporu

Piyasa değeri: €11.5b

Fresenius Medical Care Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 3/6

Fresenius Medical Care şirketinin kazançları yıllık ortalama -20.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 5.8% oranında artan oldu. Gelirler yıllık ortalama 2.7% oranında artan oldu. Fresenius Medical Care şirketinin öz sermaye getirisi 5.9% olup, net marjı 3.4% dir.

Anahtar bilgiler

-20.9%

Kazanç büyüme oranı

-20.4%

EPS büyüme oranı

Healthcare Sektör Büyümesi15.7%
Gelir büyüme oranı2.7%
Özkaynak getirisi5.9%
Net Marj3.4%
Sonraki Kazanç Güncellemesi25 Feb 2025

Yakın geçmiş performans güncellemeleri

Recent updates

Fresenius Medical Care AG (ETR:FME) Not Flying Under The Radar

Nov 01
Fresenius Medical Care AG (ETR:FME) Not Flying Under The Radar

We Think Fresenius Medical Care (ETR:FME) Is Taking Some Risk With Its Debt

Sep 26
We Think Fresenius Medical Care (ETR:FME) Is Taking Some Risk With Its Debt

These Return Metrics Don't Make Fresenius Medical Care (ETR:FME) Look Too Strong

Sep 08
These Return Metrics Don't Make Fresenius Medical Care (ETR:FME) Look Too Strong

At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Aug 20
At €34.34, Is Fresenius Medical Care AG (ETR:FME) Worth Looking At Closely?

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 02
Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

Jun 17
These 4 Measures Indicate That Fresenius Medical Care (ETR:FME) Is Using Debt Extensively

What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

May 30
What You Can Learn From Fresenius Medical Care AG's (ETR:FME) P/E

Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

May 10
Some Shareholders May Object To A Pay Rise For Fresenius Medical Care AG's (ETR:FME) CEO This Year

Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Apr 26
Fresenius Medical Care (ETR:FME) Is Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 29
Fresenius Medical Care's (ETR:FME) Shareholders Will Receive A Bigger Dividend Than Last Year

Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Mar 14
Fresenius Medical Care (ETR:FME) Has Announced That It Will Be Increasing Its Dividend To €1.19

Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

Feb 23
Fresenius Medical Care's (ETR:FME) Dividend Will Be Increased To €1.19

When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Feb 22
When Should You Buy Fresenius Medical Care AG (ETR:FME)?

Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Feb 03
Market Participants Recognise Fresenius Medical Care AG's (ETR:FME) Earnings

Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Jan 16
Fresenius Medical Care (ETR:FME) Could Be Struggling To Allocate Capital

Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Dec 29
Is Fresenius Medical Care (ETR:FME) Using Too Much Debt?

Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Nov 21
Is There Now An Opportunity In Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Oct 16
Capital Allocation Trends At Fresenius Medical Care KGaA (ETR:FME) Aren't Ideal

Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Sep 28
Is Fresenius Medical Care KGaA (ETR:FME) A Risky Investment?

Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

Aug 21
Is Now The Time To Look At Buying Fresenius Medical Care AG & Co. KGaA (ETR:FME)?

An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Jul 23
An Intrinsic Calculation For Fresenius Medical Care AG & Co. KGaA (ETR:FME) Suggests It's 34% Undervalued

Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

Jul 09
Returns On Capital At Fresenius Medical Care KGaA (ETR:FME) Paint A Concerning Picture

These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

Jun 25
These 4 Measures Indicate That Fresenius Medical Care KGaA (ETR:FME) Is Using Debt Extensively

What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

May 07
What Does Fresenius Medical Care AG & Co. KGaA's (ETR:FME) Share Price Indicate?

Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

Apr 23
Is There An Opportunity With Fresenius Medical Care AG & Co. KGaA's (ETR:FME) 49% Undervaluation?

We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Mar 24
We Think Fresenius Medical Care KGaA (ETR:FME) Is Taking Some Risk With Its Debt

Gelir ve Gider Dağılımı

Fresenius Medical Care nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

XTRA:FME Gelir, gider ve kazançlar (EUR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 2419,2396593,148199
30 Jun 2419,4155303,186212
31 Mar 2419,4744843,190224
31 Dec 2319,4544993,196232
30 Sep 2319,4634503,156228
30 Jun 2319,6225963,180236
31 Mar 2319,5546023,163235
31 Dec 2219,3986733,170229
30 Sep 2219,0487633,104234
30 Jun 2218,3938063,018225
31 Mar 2217,9578783,091222
31 Dec 2117,6199692,773221
30 Sep 2117,3729183,011205
30 Jun 2117,3449982,986198
31 Mar 2117,5811,1312,868197
31 Dec 2017,8591,1642,966194
30 Sep 2018,0391,3302,991190
30 Jun 2018,0441,3093,016187
31 Mar 2017,8321,2123,099185
31 Dec 1917,4771,2002,944168
30 Sep 1917,1961,2822,967138
30 Jun 1916,8351,2342,978122
31 Mar 1916,7041,9742,898111
31 Dec 1816,5471,9822,857114
30 Sep 1816,6761,9513,126131
30 Jun 1816,9541,9753,185133
31 Mar 1817,2111,2503,374130
31 Dec 1717,7841,2803,640111
30 Sep 1717,7711,2493,417134
30 Jun 1717,6471,2443,407145
31 Mar 1717,2011,2393,262144
31 Dec 1616,5701,1443,133147
30 Sep 1616,1011,0633,047143
30 Jun 1615,8419983,027136
31 Mar 1615,4029332,961130
31 Dec 1515,4559552,895128
30 Sep 1515,3459392,919118
30 Jun 1515,2469482,839114
31 Mar 1515,4289772,816115
31 Dec 1413,3298642,434101
30 Sep 1412,4138392,24297
30 Jun 1411,1127751,99991
31 Mar 1410,8827911,96291
31 Dec 1310,8168061,93791

Kaliteli Kazançlar: FME yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: FME 'nin mevcut net kar marjları (3.4%) geçen yılın (2.3%) sinden daha yüksektir.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: FME şirketinin kazançları son 5 yılda yılda 20.9% oranında azaldı.

Büyüme Hızlandırma: FME 'un son bir yıldaki kazanç büyümesi ( 46.5% ) 5 yıllık ortalamasını (yıllık -20.9% ) aşıyor.

Kazançlar vs. Sektör: FME geçen yılki kazanç büyümesi ( 46.5% ) Healthcare sektörünün 50.8% performansını geride bırakmadı.


Özkaynak Getirisi

Yüksek ROE: FME 'nin Özsermaye Getirisi ( 5.9% ) düşük olarak değerlendiriliyor.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin